Comparative genomics of susceptibility to mammary carcinogenesis among inbred rat strains: Role of reduced prolactin signaling in resistance of the Copenhagen strain

Carcinogenesis

Volumn 29, Issue 1, 2008, Pages 177-185

  Ren, Xuefeng ^a,b   Zhang, Xun ^a,b   Kim, Andrea S ^a   Mikheev, Andrei M ^a   Fang, Mingzhu ^c   Sullivan, Robert C ^a   Bumgarner, Roger E ^b   Zarbl, Helmut ^a,b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; JANUS KINASE; MESSENGER RNA; METHYLNITROSOUREA; PERPHENAZINE; PROLACTIN; STAT PROTEIN; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC SUSCEPTIBILITY; GENOMICS; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; RAT STRAIN; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE;

ANIMALS; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; MAMMARY NEOPLASMS, EXPERIMENTAL; PROLACTIN; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 38849179325     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm224     Document Type: Article

References (60)

1. Shepel,L.A. et al. (1999) The genetic components of susceptibility to breast cancer in the rat. Prog. Exp. Tumor Res., 35, 158-169.
2. Isaacs,J.T. (1986) Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res., 46, 3958-3963.
3. Maita,K. et al. (1987) Spontaneous tumors in F344/DuCrj rats from 12 control groups of chronic and oncogenicity studies. J. Toxicol. Sci., 12, 111-126.
4. Gould,M.N, et al. (1991) Genetic regulation of mammary carcinogenesis in the rat by susceptibility and suppressor genes. Environ. Health Perspect., 93, 161-167.
5. Segaloff,A. (1974) The role of the ovary in estrogen production of mammary cancer in the rat. Cancer Res., 34, 2708-2710.
6. Wood,G.A. et al. (2002) Tissue-specific resistance to cancer development in the rat: Phenotypes of tumor-modifier genes. Carcinogenesis, 23, 1-9.
7. Shepel,L.A. et al. (1998) Genetic identification of multiple loci that control breast cancer susceptibility in the rat. Genetics, 149, 289-299[erratum appears in Genetics, 1998, 149, 1627].
8. Freeman,M.E. et al. (2000) Prolactin: Structure, function, and regulation of secretion. Physiol. Rev., 80, 1523-1631.
9. Welsch,C.W. (1978) Prolactin and the development and progression of early neoplastic mammary gland lesions. Cancer Res., 38, 4054-4058.
10. Welsch,C.W. et al. (1979) Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion. J. Natl Cancer Inst., 63, 1121-1124.
11. Russo,J. et al. (1996) Experimentally induced mammary tumors is rats. Breast Cancer Res. Treat., 39, 7-20.
12. Hankinson,S.E. et al. (1999) Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J. Natl Cancer Inst., 91, 629-634.
13. Clevenger,C.V. et al. (2003) The role of prolactin in mammary carcinoma. Endocr. Rev., 24, 1-27.
14. Clevenger,C. et al. (1997) Prolactin as an autocrine/paracrine factor in breast tissue. J. Mammary Gland Biol. Neoplasia, 2 59-68.
15. Tworoger,S. et al. (2006) Prolactin and breast cancer risk. Cancer Lett., 243, 160-169.
16. Clevenger,C. et al. (1995) Expression of prolactin and receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am. J. Pathol., 146, 695-705.
17. Ginsburg,E. et al. (1995) Prolactin synthesis and secretion by human breast cancer cells. Cancer Res., 55, 2591-2595.
18. Steinmetz,R. et al. (1993) Transcription of prolactin gene in milk secretory cells of the rat mammary gland. J. Endocrinol., 136 271-276.
19. Mershon,J. et al. (1995) Prolactin is a local growth factor in rat mammary tumors. Endocrinology, 136, 3619-3623.
20. Kurtz,A. et al. (1993) Mammary epithelial cells of lactating rats express prolactin messenger ribonucleic acid. Biol. Reprod., 48 1095-1103.
21. Le Provost,F. et al. (1994) Prolactin gene expression in ovine and caprine mammary gland. Neuroendocrinology, 60, 305-313.
22. Ben-David,M. (1968) Mechanism of induction of mammary differentiation is Sprague-Dawley female rats by perphenazine. Endocrinology, 83 1217-1223.
23. Russof,I.H. et al. (1978) Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimetnylbenz[a]anthracene. J. Natl Cancer Inst., 61, 1439-1449.
24. Korn,E. et al. (2004) Controlling the number of false discoveries: application to high-dimensional genomic data. J. Stat. Plan. Inference, 124, 379-398.
25. Simon,R. et al. (2003) Design and Analysis of DNA Microarray Investigations. Springer-Verlag, New York.
26. Wright,G.W. et al. (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics, 19, 2448-2455.
27. Canzian,F. (1997) Phylogenetics of the laboratory rat Rattus norvegicus. Genome Res., 7, 262-267.
28. Blakely,C.M. et al. (2006) Hormone-induced protection aginst mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res., 66, 6421-6431.
29. Stringer,B. et al. (1989) Effect of raised serum prolactin on breast development. J. Anat., 162, 249-261.
30. Gould,M.N. et al. (1978) Effects of endocrinologic conditions associated with acute versus chronic lactation on the incidence of mammary carcinomas in irradiated rats: Brief communication. J. Natl Cancer Inst., 60, 469-471.
31. Gould,M.N. (1986) Inheritance and site of expression of genes controlling susceptibility to mammary cancer in an inbred rat model. Cancer Res., 46, 1199-1202.
32. Briand,P. (1983) Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review). Anticancer Res., 3, 273-281.
33. Lu,S.J. et al. (1992) Formation and repair of O6-methylguanine and methylation of the Ha-ras proto-oncogene-by N-methyl-N nitrosourea are not associated with mammary tumor resistance in the Copenhagen rat. Carcinogenesis, 13, 857-861.
34. Sukumar,S. et al. (1983) Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras- 1 locus by single point mutations. Nature, 306, 658-661.
35. Zarbl,H. et al. (1985) Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature, 315, 382-385.
36. Zarbl,H. et al. (1986) Activation of H-ras-1 oncogenes by chemical carcinogenes. Basic Life Sci., 38, 385-397.
37. Shan,L. et al. (2005) Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas. Toxicol. Pathol., 33, 768-775.
38. Rose-Hellekant,T.A. et al. (2003) Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene, 22, 4664-4674.
39. Tomblyn,S. et al. (2005) The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice. Int. J. Oncol., 27, 1381-1389.
40. Moorman,P.G. et al. (2003) Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology, 14, 307-314.
41. Blankenstein,M.A. et al. (1984) Prolactin concentration in plasma and susceptibility to marnmary tumors in female rats from different strains treated chronically with estradiol-17 beta. Breast Cancer Res. Treat., 4, 137-141.
42. Boyns,A.R. et al. (1973) Basal prolactin blood levels in three strains of rat with differing incidence of 7,12-dimethylbenz(a)anthracene induced mammary tumours. Eur. J. Cancer, 9, 169-171.
43. Das,R. et al. (1995) Transduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor. Mol. Endocrinol., 9, 1750-1759.
44. Hennighausen,L. et al. (1997) Prolactin signaling in mammary gland development. J. Biol. Chem., 272, 7567-7569.
45. Piccoletti,R. et al. (1994) Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem. J., 303, 429-433.
46. Buckley,A. et al. (1994) Prolactin-induced phosphorylation and nuclear translocation of MAP kinase in Nb2 lymphoma cells. Biochem. Biophys. Res. Commun., 204, 1158-1164.
47. Hennighausen,L. et al. (1997) Developing a mammary gland is a stat affair. J. Mammary Gland Biol. Neoplasia, 2, 365-372.
48. Dunning,W. et al. (1953) Strain differences in response to estrone and the induction of mammary gland, adrenal, and bladder cancer in rats. Cancer Res., 13, 147-152.
49. Shellabarger,C. et al. (1978) Rat differences in mammary tumor induction with estrogen and neutron radiation. J. Natl Cancer Inst. 61, 1505-1508.
50. Cha,R.S. et al. (1996) Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontancous mammary tumorigenesis in rats. Carcinogenesis, 17, 2519-2524.
51. Lu,S.J. et al. (1992) Mammary tumor induction by N-methyl- N-nitrosourea in genetically resistant Copenhagen rats. Cancer Res., 52, 5037-5041.
52. Erb,R.J. et al. (1982) Serum prolactin level increase in normal subjects following administration of perphenazine oral dosage forms: possible application to bioavailability testing. J. Pharm. Sci., 71, 883-888.
53. Takahashi,H. et al. (1995) Induction of mammary carcinomas by the direct application of crystalline N-methyl-N-nitrosourea onto rat mammary gland. Cancer Lett., 92, 105-111.
54. Shull,J.D. et al. (2001) Susceptibility to estrogen-induced mammary cancer segregates as an incompletely dominant phenotype in reciprocal crosses between the ACI and Copenhagen rat strains. Endocrinology, 142, 5124-5130.
55. Sinha,Y.N. et al. (1979) Serum, pituitary and urine concentrations of prolactin and growth hormone in eight strains of mice with varying incidence of mammary tumors. Int. J. Cancer, 24, 430-437.
56. Wang,B. et al. (1991) Overcoming the activity of mammary carcioma suppressor gene in Copenhagen rats by v-H-ras oncogene transfer into mammary epithelial cells in situ. Cancer Res., 51, 5298-5303.
57. Ben-David,M. et al. (1970) Acute changes in blood and pituitary prolactin after a single injection of perphenazine. Neuroendocrinology, 6, 336-342.
58. Guzman,R.C. et al. (1999) Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc. Natl Acad. Sci. USA, 96, 2520-2525.
59. Dickson,R.A. et al. (1999) Neuroleptic-induced hyperprolactinemia. Schizophr. Res., 35 (suppl.), S75-S86.
60. Wang,P.S. et al. (2002) Dopamine antagonists and the development of breast cancer. Arch. Gen. Psychiatry, 59, 1147-1154.